Bringing regenerative medicines to the clinic: the future for regulation and reimbursement

This Open Access Review by authors from Canadian and UK institutes looks at the methods to support the assessment of value for regenerative medicine products and services and the synergies that exist between market authorization and reimbursement regulations and practices.

Go to the profile of Regenerative Medicine
Aug 26, 2016
Upvote 0 Comment

Regenerative medicine, likely to be a costly therapeutic option, is coming of age in an era of cost-constrained health systems facing an aging population and high-cost new therapies and technologies that do not necessarily improve health outcomes. Value assessment is must therefore be assessed as part of the clinical translation process: this article therefore discusses topics such as methods to support assessments of value and configuring adaptive licensing frameworks for regulation and reimbursement, specifically reporting on discussions from two workshops sponsored by NICE, University of Alberta, Cell and Gene Therapy Catapult and Centre for Commercialization of Regenerative Medicine (CCRM).

Bubela T, McCabe C, Archibald P et al. Bringing regenerative medicines to the clinic: the future for regulation and reimbursement. Regen. Med. 10(7), 897–911 (2016).

Go to the profile of Regenerative Medicine

Regenerative Medicine

Journal, Future Science Group

Regenerative Medicine is an award-winning peer-reviewed journal, in print and web formats. The journal provides a forum to address the important challenges and advances in stem cell research and regenerative medicine, delivering this essential information in concise, clear and attractive article formats. Among other indexing services Regenerative Medicine is listed by MEDLINE/Index Medicus, EMBASE/Excerpta Medica, Chemical Abstracts, Science Citation Index Expanded™ (SciSearch®), Emcare, Biological Abstracts, BIOSIS Previews, Biotechnology Citation Index®, Journal Citation Reports/Science Edition®, Scopus® with an Impact Factor of 2.786 (2014). Each issue contains expertly drafted Reviews, Original Research articles, Perspectives, Editorials, topical insight from international leaders in their field, and additional added-value content. The Senior Editor of the journal is Professor Chris Mason, University College London. You can find out more about Regenerative Medicine at our website (, where you can find the aims and scope of the journal and details of our international editorial board.

No comments yet.